Tested eye drops for dry eye relief and safety
Part of Eyes & vision clinical trials.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had dry eye symptoms in both eyes for at least 3 months and used artificial tears
- At least one eye has an Oxford score between 4 and 9
- At least one eye shows an objective sign of tear shortage on testing
- You have health insurance
- You have not worn contact lenses in the past 2 months
- You have not used preservative-containing artificial tears in the past 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This trial tests a new eye drop called PRO-240 versus Optive artificial tears in healthy adults. You will attend several visits over a few weeks and use the assigned drops as directed. The goal is to see if the new drop is as safe and comfortable as the standard one.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.